US pharmacy pricing
Where to Find the Cheapest Recombinate Price
Lowest price found · US pharmacies
$21.15/fill
for Recombinate, across the pharmacies in our data
US pharmacy prices — 1241-1800unit
| Pharmacy | Discount-card price | Regular cash price | Average retail |
|---|---|---|---|
 Kroger Pharmacy | $21.15Lowest | $24.15 | $2,519.00 |
 Harris Teeter Pharmacy | $21.15Lowest | $24.15 | $2,519.00 |
 Costco | $22.68 | $25.68 | $2,519.00 |
 Walgreens | $23.84 | $26.84 | $2,519.00 |
 Publix | $28.21 | $28.21 | $2,519.00 |
"Discount-card price" reflects a standard prescription discount card, not insurance. Prices change often — confirm at the pharmacy before filling.
Frequently asked questions
What's the cash price for Recombinate (Recombinate) in the US?
At the US pharmacies in our data, the lowest listed discount-card price for Recombinate is around $21.15. Prices vary by pharmacy, dosage, and pack size, so use the table above to compare specific options near you.
Is a generic version of Recombinate available?
Generic and brand-name pricing for Recombinate is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.
What determines the cost of Recombinate with insurance?
The cost of Recombinate with insurance varies considerably depending on your specific plan's formulary, deductible, and co-pay structure. It's essential to contact your insurance provider directly to confirm coverage details and your expected out-of-pocket expense. If your insurance does not cover Recombinate or if your co-pay is high, you may be able to use pharmacy savings programs or manufacturer coupons to lower your cost at the pharmacy counter. Patients with Medicare or Medicaid should also verify their plan's coverage, as savings programs may be an option if the medication is not covered.
Is there a generic version of Recombinate?
No. Recombinate is a brand-name medication manufactured by Takeda Pharmaceuticals America. A biosimilar or generic equivalent is not currently available in the United States.